Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Apellis Pharmaceuticals (APLS) Tax Rate (2021 - 2025)

Historic Tax Rate for Apellis Pharmaceuticals (APLS) over the last 5 years, with Q3 2025 value amounting to 0.28%.

  • Apellis Pharmaceuticals' Tax Rate rose 13300.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.65%, marking a year-over-year increase of 46000.0%. This contributed to the annual value of 0.59% for FY2024, which is 1900.0% down from last year.
  • Latest data reveals that Apellis Pharmaceuticals reported Tax Rate of 0.28% as of Q3 2025, which was up 13300.0% from 1.2% recorded in Q2 2025.
  • In the past 5 years, Apellis Pharmaceuticals' Tax Rate registered a high of 0.88% during Q4 2022, and its lowest value of 1.63% during Q4 2023.
  • Moreover, its 5-year median value for Tax Rate was 0.3% (2024), whereas its average is 0.41%.
  • In the last 5 years, Apellis Pharmaceuticals' Tax Rate crashed by -25100bps in 2023 and then surged by 13300bps in 2025.
  • Over the past 5 years, Apellis Pharmaceuticals' Tax Rate (Quarter) stood at 0.24% in 2021, then skyrocketed by 468bps to 0.88% in 2022, then tumbled by -286bps to 1.63% in 2023, then skyrocketed by 56bps to 0.73% in 2024, then skyrocketed by 138bps to 0.28% in 2025.
  • Its Tax Rate was 0.28% in Q3 2025, compared to 1.2% in Q2 2025 and 0.37% in Q1 2025.